Skip to main content

1 Result(s)

within Fábio Franke Remove this filter

and

  1. Article

    Open Access

    heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer

    HER2-positive, estrogen receptor-positive breast cancer (HER2+, ER+ BC) is a distinct disease subtype associated with inferior response to chemotherapy plus HER2-targeted therapy compared with HER2+, ER-negati...

    Sherko Kuemmel, Catherine Harper-Wynne, Yeon Hee Park, Fábio Franke… in BMC Cancer (2024)

    Download PDF (2576 KB) View Article